Medical network, June 15, June 14, the ministry of commerce issued the medicine circulation industry in 2016 to run statistical analysis report (hereinafter referred to as the "report"), in 2016 made a panoramic scanning medicine circulation market in China.
The report provides a good view of the entire circulation market, with its current status, current trends and future opportunities. Here are the key points of the report:
▍ 12875 medicine group, the sales of the only three
In 2016, it accounted for 70.9 percent of the country's total sales, up 2.0 percent year on year.
Four national champions accounted for 37.4% of the country's sales over the same period, up by half a percentage point over the same period. The 15 regional champions accounted for 18.4 per cent, up 1.1 percentage points from a year earlier. The last group of companies in the ranking grew from 1.15 billion yuan in 2015 to 1.24 billion yuan in 2016.
With the implementation of the reform policies, the consolidation of the pharmaceutical industry has accelerated. The data shows that the wholesale companies that have a certain size in the market are actively planning and strengthening their control.
▍ medicine quantity reduction, higher retail chain
As of the end of November 2016, there were 12,975 wholesale pharmaceutical enterprises nationwide. There were 5,609 pharmaceutical retail chains and 220,703 outlets. Retail pharmacies were 226331, with a total of 447,034 stores.
In contrast to the ministry of commerce's 2015 figures, the number of drug approvals fell by 533 in one year. The number of retail chains increased by 628 and the number of stores increased by 15,808. The number of retail monomers fell by 16,831 and 1,026 in stores.
▍ chemical medicine overwhelming advantage, proprietary Chinese medicine
According to the sales category classification, western medicine dominates sales, sales account for 74.4% of the total amount of seven class of pharmaceutical sales, followed by proprietary Chinese medicine class (15.0%), traditional Chinese medicine class accounted for 3.0%, medical equipment class (3.3%), chemical reagent class (1.2%), glassware class accounted for 0.1%, other classes (3.0%). (see the end of the article: sales in the provinces of western medicine and Chinese medicine.)
In 2015, the western medicine class accounted for 74.2 percent, 14.6 percent of Chinese medicine and 3.6 percent of Chinese herbs. (note: the western medicine includes chemical agents, chemical raw materials and their preparations, radioactive drugs, but not including the chemical reagents.)
▍ 3 10 provinces and cities, such as 6 in total sales
The top 10 cities in 2016 were guangdong, Beijing, Shanghai, zhejiang, jiangsu, anhui, shandong, henan, sichuan and yunnan. These provincial and municipal sales accounted for 64.2 per cent of the country's total sales, up 0.4 percentage points from a year earlier. (see the end of the article: sales across the country)
In 2016, the six regional sales accounts for the proportion of total sales, respectively, 37.4%, 16.2% of north China, central south east China 23.7% 13.0%, 5.1% 5.1% of northeast China, northwest and southwest. (east China: Shanghai, jiangsu, zhejiang, anhui, fujian, jiangxi, shandong)
▍ 16 medicine group of value exceeds ten billion
In 2016, there are two new companies listed in the pharmaceutical circulation industry, respectively. Companies that value of 10 billion yuan of above 16, sinopharm, medicine, China resources medicine, Shanghai east China pharmaceutical, kyushu, its consistent, rui kang medicine, Chinese medicine, tongji hall, haiwang biology, share, common people, liuzhou medical and hall hall, yi feng pharmacy and fine things.
The market value of China drug holdings, Shanghai pharmaceuticals and China resources medicine is more than 40 billion yuan. A total of 86 outbound investment activities disclosed by companies listed in the pharmaceutical circulation industry have been disclosed in 2016, involving a total of 12.5 billion yuan.
▍ medicine group, retail top list released, medicine group of more than eight new faces
The report released the list of the top 100 drugs and retail companies for 2016. Compared with 2015, there are eight new top 100. The following chart:
|
